Executive record

Juan Carlos Jaen, Ph.D.

President at Arcus Biosciences, Inc.

Follow
More
Challenge a Claim

Alpha ID: alpha:person:juan-carlos-jaen-ph-dVersion: public-0As of: 2026-09-29

Not yet claimed6 published Claims2 sources
  • Executive

Key Claims

Biography

Co-founder of Arcus Biosciences and President since May 2015. Previously co-founded Flexus Biosciences and served as President and Head of R&D there, and prior to that was Chief Scientific Officer at ChemoCentryx and VP of Chemistry at Amgen.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.

Executive career

  1. Current · dates not publishedPresident · Arcus Biosciences, Inc.
  2. 2026 to end not publishedExecutive title: President · Organization not publishedRCUS DEF 14A executive officers

Claims

Conflicts and accountability

Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.

Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.

Evidence, history and coverage

Additional published Claims

Published evidence records

2 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. RCUS DEF 14A executive officers

    sec filing · Source published: Apr 21, 2026 · Retrieved: May 5, 2026

    Supports 5 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 5, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 5, 2026
    • Executive company: Executive at Arcus Biosciences, Inc. · Claim reviewed: May 5, 2026
    • Executive title: Executive title: President · Claim reviewed: May 5, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 5, 2026

  2. Open source

    sec def 14a · Source published: Apr 21, 2026 · Retrieved: Sep 12, 2026

    Supports 1 claim
    • Professional Role: President at Arcus Biosciences, Inc. · Claim reviewed: Sep 12, 2026